Gubra A S (GUBRF) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by. My name is Karen, and I will be your conference separator today. At this time, I would like to welcome everyone to the Gubra Quarter 3 2025 earnings release. All lines have been placed on mute to prevent any background noise. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star followed by the number one on your telephone keypad. To withdraw your question, you may press star followed by the number one again. I will now turn the call over to Marcus Warfield, CEO. Please go ahead. Good morning, everybody. Also, welcome from my side. My name is Marcus Warfield. I'm the CEO of Coupa. I'm joined here by Luisi, our CSO, and our CFO, Christian. So we'll start with our presentation. I will give a general overview followed by Luise and then the financial results by Christian before I wrap up. As you know, at the core of our strategy, we have a dual business model. We have our discovery partnerships, our key value driver and our CEO services, which are a strong enabler. for our internal pipeline as well as our partnering. Our CEO business has had remarkable growth over the long run. We had 30% growth year-on-year and we deliver great data and service to 16 out of top 20 customers in the pharma and biotech area. Our primary focus has been obesity, and I think our recent deal with Appion Ammon has demonstrated and validated our business model. Now, let's look at the first nine months. And I think this chart speaks for itself. Obviously, it's going to be a record year for HUBRA, both on the revenue side as well as the margin side driven by the upfront of the extraordinary business update, which has brought us significant liquidity. In terms of highlights for 2025, Of course, our UCM2 program ha...